96
Participants
Start Date
February 4, 2022
Primary Completion Date
January 19, 2023
Study Completion Date
June 30, 2023
Adherence Intervention
"Intervention:~* Adherence Support Team (patient, parent or a significant other, Coach)~* Standardized educational videos on immunosuppressive medications, rejection, and improving adherence~* Identification of adherence barriers, self-efficacy for medication-taking, and allocation of treatment responsibility~* 'Action-Focused Problem-Solving' to address barriers selected as most important by the patient~Device:~* Electronic pillbox monitoring with text message and/or audio/visual dose reminders and access to e-pillbox website~* Feedback of electronic monitoring data at increasing intervals between initiation of the intervention at 4-week and exit at 14-week."
Healthy living education intervention
"Intervention:~* Standardized educational videos on immunosuppressive medications, rejection, and improving adherence~* Healthy living topic discussion at increasing intervals between 4-wk and 14-wk visits~* 'Action-Focused Problem-Solving' to address barriers on healthy living topic selected by the patient~Device:~• Electronic adherence monitoring without dose reminders or feedback (enrollment to 14w)"
St-Louis Children's Hospital, St Louis
Temple University, Philadelphia
University of Pittsburgh Medical Center, Pittsburgh
Seattle Children's Hospital, Seattle
BC Children's Hospital, Vancouver
University of Toronto Hospital for Sick Children, Toronto
Montreal Children's Hospital, Montreal
CHU Ste-Justine, Montreal
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
McGill University Health Centre/Research Institute of the McGill University Health Centre
OTHER